Biocomm capital fund launched
11 June, 2002 by Tanya HollisVictorian biosciences commercialisation group Biocomm has launched an $11.5 million capital pool to help take the state's research to the market.
WEHI's Caples nets top Vic biotech job
11 June, 2002 by Tanya HollisFormer head of business development at the Walter and Eliza Hall Institute Dr Amanda Caples has been appointed Victorian Biotechnology Director.
Jobs lost as GroPep facility shuts
11 June, 2002 by Tanya HollisMore than 30 staff at the former Biotech Australia (BA) will lose their jobs in the operational restructure planned by Adelaide growth factor company GroPep.
NSW govt awards aim to reverse the 'brain-drain'
07 June, 2002 by Melissa TrudingerGarvan Institute neurobiologist Dr Bryce Vissel is one of the first recipients of the NSW government's inaugural BioFirst Awards.
Bio 2002 exodus begins
06 June, 2002 by Pete YoungAn exodus of Australian bioscience professionals heading for Toronto and the start of the Bio 2002 conference and exhibition has begun.
Nextec BioSciences and council combine to foster biotech
06 June, 2002 by Tanya HollisInvestment banking group Nextec BioSciences has joined forces with the Melbourne City Council to establish an entrepreneurial incubator for biobusinesses.
BioStart kicks off with Mimetica
06 June, 2002 by Pete YoungThe first investment in a young biotech company has been made by the $6 million BioStart pre-seed fund set up a year ago by the Queensland government.
Rights issue to fund Analytica's new biotech strategy
06 June, 2002 by Pete YoungA $1.3 million rights issue by Analytica Ltd will test investor attitudes toward young biotechs who ask shareholders for a second chance after crashing on the first attempt.
Public gets a say on research focus
05 June, 2002 by Iain ScottThe Commonwealth government is hosting nationwide forums to help it set research priorities.
GTG sells Victorian mining assets
05 June, 2002 by Melissa TrudingerGenetic Technologies (ASX: GTG) has severed more of its ties with its former life as gold mining and exploration company Duketon Goldfields by offloading its remaining Victorian mining assets.
Bridges to retire from Panbio
05 June, 2002 by Melissa TrudingerQueensland-based diagnostics company Panbio has announced that CEO and co-founder Mel Bridges will retire in early 2003.
O'Brien Institute in analysis deal with UK biotech
04 June, 2002 by Tanya HollisA $1 million deal to analyse molecular changes in tumours has been signed between Melbourne's Bernard O'Brien Institute of Microsurgery (BOBIM) and a private London biotech.
HPLC market report: Cents and sensitivity
04 June, 2002 by Melissa TrudingerEase of use, reliability and service and support are the main things that scientists consider when buying a new chromatography system. But previous familiarity with a particular brand is also a major factor.
Billionare buys Amrad stake
04 June, 2002 by Tanya HollisIn a much-needed show of investor support, cardboard king Richard Pratt has become a substantial shareholder of Amrad Corporation.
New Zealand joins synchrotron project
03 June, 2002 by Tanya HollisA New Zealand representative is to join the Australian Synchrotron Project's scientific advisory committee, cementing a trans-Tasman link between users of the new facility.
